REQUEST A DEMO
Total
USD $0.00
Search more companies

Novamed S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novamed S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Novamed S.A.S. is a company in Colombia, with a head office in Barranquilla. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on April 17, 1990. 388 (2023) employees currently work for Novamed S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 69.34% in 2022. A growth of 58.82% was recorded in its total assets. The net profit margin of Novamed S.A.S. increased by 2.62% in 2022.

Headquarters
Cl 79B Cr 78C 21
Barranquilla; Atlantico;

Contact Details: Purchase the Novamed S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Novamed S.A.S. report to view the information.
Outstanding Shares:
Purchase the Novamed S.A.S. report to view the information.
Registered Capital:
Purchase the Novamed S.A.S. report to view the information.
Incorporation Date:
April 17, 1990
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Novamed S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
69.34%
Total operating revenue
69.28%
Operating profit (EBIT)
122.63%
EBITDA
122.18%
Net Profit (Loss) for the Period
121.03%
Total assets
58.82%
Total equity
43.12%
Operating Profit Margin (ROS)
4.22%
Net Profit Margin
2.62%
Return on Equity (ROE)
13.96%
Debt to Equity Ratio
3.7%
Quick Ratio
-0.39%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?